Company profile: Artegraft
1.1 - Company Overview
Company description
- Provider of biologic vascular grafts derived from bovine carotid arteries, processed and sold for implantation primarily in hemodialysis patients, offering surgeons a biological alternative to synthetic grafts.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Artegraft
FoxHollow Technologies
HQ: United States
Website
- Description: Provider of medical devices for the treatment of peripheral artery disease (PAD) and other cardiovascular disease, including the SilverHawk Plaque Excision System, a minimally-invasive catheter system that removes plaque to reopen narrowed or blocked arteries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FoxHollow Technologies company profile →
Vivasure Medical
HQ: Ireland
Website
- Description: Provider of sutureless, fully absorbable vascular closure devices for large-bore vessel punctures in procedures such as TAVR, TEVAR, and EVAR. Products include the PerQseal Closure Device, a synthetic implant, and PerQseal+, an enhanced version with an improved bioabsorbable patch to manage more complex patient anatomies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vivasure Medical company profile →
Hemosphere
HQ: United States
Website
- Description: Provider of proprietary graft-based vascular access solutions for dialysis, marketing the HeRO (Hemodialysis Reliable Outflow) Graft, a fully subcutaneous arteriovenous access solution for end-stage renal disease hemodialysis patients with limited access options and central venous obstruction, designed to maintain long-term access without venous anastomosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hemosphere company profile →
Nuubo
HQ: Spain
Website
- Description: Provider of wireless, wearable technologies for physiological monitoring via the nECG DYNAMIC PLATFORM to perform and read electrocardiograms remotely. Offerings include the Nuubo Textile Electrode for high-quality ECG during daily activities, a 30-day Nuubo Monitoring Report, Nuubo Device Installation guidance, the myNuubo app for symptom tracking and charge reminders, and scientific research in validation, risk stratification, arrhythmias, and cardiac rehabilitation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nuubo company profile →
Spectrum Dynamics Medical
HQ: United States
Website
- Description: Provider of innovative high definition functional imaging technology that delivers high-speed, high-resolution nuclear images in compact systems designed to meet clinical and workflow demands, including BroadView™ Technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spectrum Dynamics Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Artegraft
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Artegraft
2.2 - Growth funds investing in similar companies to Artegraft
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Artegraft
4.2 - Public trading comparable groups for Artegraft
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →